Year-end Sale % OFF 
Abstract
Airway infantile hemangiomas can cause life-threatening airway compromise from the first year of life. Diagnosis, treatment protocols and outcome measures are not standardized for this condition, making systematic assessment of treatments and outcomes difficult. This article summarizes the treatment options in use and provides an overview of their benefits and drawbacks. It also emphasizes the need for further investigation in this field and discusses the standardization that is required for such research to proceed in a useful manner. The article is divided into discussions of airway infantile hemangioma in general, medical therapy and surgical therapy. It concludes with predictions about the near future of airway infantile hemangioma research and therapy.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
